SARS-CoV-2 Seropositivity in Nursing Home Staff and Residents during the First SARS-CoV-2 Wave in Flanders, Belgium

被引:0
|
作者
De Rop, Liselore [1 ]
Vercruysse, Hanne [2 ]
Alenus, Ulysse [3 ]
Brusselmans, Judith [3 ,4 ]
Callens, Steven [5 ]
Claeys, Maud [3 ]
De Coene, Nimphe [6 ]
Persyn, Peter [7 ]
Padalko, Elizaveta [8 ,9 ]
Heytens, Stefan [6 ]
Verbakel, Jan Y. [1 ]
Cools, Piet [3 ]
机构
[1] Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, LUHTAR, B-3000 Leuven, Belgium
[2] Liantis Occupat Hlth Serv, Res & Analyt, B-8000 Brugge, Belgium
[3] Univ Ghent, Fac Med & Hlth Sci, Dept Diag Sci, B-9000 Ghent, Belgium
[4] Univ Ghent, Fac Med & Hlth Sci, Dept Human Struct & Repair, B-9000 Ghent, Belgium
[5] Ghent Univ Hosp, Dept Internal Med & Infect Dis, B-9000 Ghent, Belgium
[6] Univ Ghent, Fac Med & Hlth Sci, Dept Publ Hlth & Primary Care, B-9000 Ghent, Belgium
[7] Korian Belgium NH, Med Dept, B-2550 Kontich, Belgium
[8] Univ Hosp Ghent, Lab Clin Biol, B-9000 Ghent, Belgium
[9] Univ Ghent, Dept Diag Sci, B-9000 Ghent, Belgium
来源
VIRUSES-BASEL | 2024年 / 16卷 / 09期
关键词
nursing homes; COVID-19; SARS-CoV-2; seroprevalence; RT-PCR testing; reinfection; REINFECTION; INFECTION; COVID-19;
D O I
10.3390/v16091461
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
(1) Background: early in the COVID-19 pandemic, reverse transcription polymerase chain reaction (RT-PCR) testing was limited. Assessing seroprevalence helps understand prevalence and reinfection risk. However, such data are lacking for the first epidemic wave in Belgian nursing homes. Therefore, we assessed SARS-CoV-2 seroprevalence and cumulative RT-PCR positivity in Belgian nursing homes and evaluated reinfection risk. (2) Methods: we performed a cross-sectional study in nine nursing homes in April and May 2020. Odds ratios (ORs) were calculated to compare the odds of (re)infection between seropositive and seronegative participants. (3) Results: seroprevalence was 21% (95% CI: 18-23): 22% (95% CI: 18-25) in residents and 20% (95% CI: 17-24) in staff. By 20 May 2020, cumulative RT-PCR positivity was 16% (95% CI: 13-21) in residents and 8% (95% CI: 6-12) in staff. ORs for (re)infection in seropositive (compared to seronegative) residents and staff were 0.22 (95% CI: 0.06-0.72) and 3.15 (95% CI: 1.56-6.63), respectively. (4) Conclusion: during the first wave, RT-PCR test programmes underestimated the number of COVID-19 cases. The reinfection rate in residents was 3%, indicating protection, while it was 21% in staff, potentially due to less cautious health behaviour. Future outbreaks should use both RT-PCR and serological testing for complementary insights into transmission dynamics.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Mobility and the spatial spread of sars-cov-2 in Belgium
    Rollier, Michiel
    Miranda, Gisele H. B.
    Vergeynst, Jenna
    Meys, Joris
    Alleman, Tijs W.
    Baetens, Jan M.
    [J]. MATHEMATICAL BIOSCIENCES, 2023, 360
  • [32] Usefulness of the Lumiradx™ SARS-COV-2 antigen test in nursing home
    Bergas, Alba
    Rivera, Samuel
    Torrecillas, Miriam
    Cuervo, Guillermo
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2022, 40 (07): : 404 - 405
  • [33] The Seroprevalence and Seropositivity of SARS-CoV-2 among Healthcare Workers during the Third Pandemic Wave
    Vaezi, Atefeh
    Fakhim, Hamed
    Abbasi, Saeed
    Masoudi, Soraya
    Rizi, Mahnaz Hosseini
    Javanmard, Shaghayegh Haghjooy
    [J]. ANTIBODIES, 2023, 12 (01)
  • [34] Heart transplantation in the UK during the first wave of the SARS-CoV-2 pandemic
    Hardman, Gillian
    Sutcliffe, Ruth
    Hogg, Rachel
    Mumford, Lisa
    Grocott, Laura
    Jerrett, Lorraine
    Mead-Regan, Sarah-Jane
    Nuttall, Jane
    Dunn, Stephanie
    Seeley, Philip
    Quigley, Richard
    Dalzell, Johnathan R.
    Al-Attar, Nawwar
    Parameshwar, Jayan
    Fisher, Andrew J.
    Booth, Karen
    Dark, John H.
    [J]. CLINICAL TRANSPLANTATION, 2021, 35 (05)
  • [35] Skin lesions in children during the first wave of the SARS-CoV-2 pandemic
    Gallego, Begona Carazo
    Pedraz, Laura Martin
    Zavala, Rocio Galindo
    Cuello, Mercedes Rivera
    Gradolph, Concepcion Mediavilla
    Cuadros, Esmeralda Nunez
    [J]. MEDICINA CLINICA, 2021, 157 (01): : 33 - 37
  • [36] SARS-CoV-2: The Second Wave in Europe
    Fokas, Athanassios S.
    Kastis, George A.
    [J]. JOURNAL OF MEDICAL INTERNET RESEARCH, 2021, 23 (05)
  • [37] Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines
    Hromic-Jahjefendic, Altijana
    Lundstrom, Kenneth
    Adilovic, Muhamed
    Aljabali, Alaa A. A.
    Tambuwala, Murtaza M.
    Serrano-Aroca, Angel
    Uversky, Vladimir N.
    [J]. AUTOIMMUNITY REVIEWS, 2024, 23 (03)
  • [38] SARS-CoV-2 HaploGraph: visualization of SARS-CoV-2 haplotype spread in Japan
    Nakagawa, So
    Katayama, Toshiaki
    Jin, Lihua
    Wu, Jiaqi
    Kryukov, Kirill
    Oyachi, Rise
    Takeuchi, Junko S.
    Fujisawa, Takatomo
    Asano, Satomi
    Komatsu, Momoka
    Onami, Jun-ichi
    Abe, Takashi
    Arita, Masanori
    [J]. GENES & GENETIC SYSTEMS, 2023, 98 (05) : 221 - 237
  • [39] Nachweismethoden von SARS-CoV-2 in GewebeMethods of SARS-CoV-2 detection in tissue
    Saskia von Stillfried
    Peter Boor
    [J]. Der Pathologe, 2021, 42 (2): : 208 - 215
  • [40] Impact of Antenatal SARS-CoV-2 Exposure on SARS-CoV-2 Neutralization Potency
    Chiang, Chia-Jung
    Hsu, Wei-Lun
    Su, Mei-Tsz
    Ko, Wen-Chien
    Hsu, Keng-Fu
    Tsai, Pei-Yin
    [J]. VACCINES, 2024, 12 (02)